![Stefan Sperl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Sperl
Operationeel Directeur bij
KIORA PHARMACEUTICALS, INC.
Profiel
Stefan Sperl was the founder of Panoptes Pharma GmbH, founded in 2013, holding the title of Chief Operating Officer.
Dr. Sperl is currently the Executive Vice President-CMC & Operations at Kiora Pharmaceuticals, Inc. Formerly, Project Manager at Nabriva Therapeutics GmbH.
Education includes a doctorate from Max Planck Institute of Biochemistry.
Actieve functies van Stefan Sperl
| Bedrijven | Functie | Begin |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Operationeel Directeur | - |
Eerdere bekende functies van Stefan Sperl
| Bedrijven | Functie | Einde |
|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Corporate Officer/Principal | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Oprichter | - |
Opleiding van Stefan Sperl
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Max Planck Institute of Biochemistry
 Max Planck Institute of Biochemistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Develops molecule drugs to treat eye diseases | Health Technology |
